1 / 10

Advancements in Services Research: Enhancing Drug Abuse Treatment and Prevention Strategies

This presentation by Dr. Redonna K. Chandler, Chief of the Services Research Branch at NIDA, explores the evolution and enhancement of services research within drug abuse treatment and prevention. Highlighting the importance of integrating health services (HS) data into clinical trials, the discussion emphasizes economic evaluations, client treatment costs, and stakeholder collaboration. By leveraging the rich environment of the Clinical Trials Network (CTN), the aim is to improve outcomes, inform mechanisms of action, and prepare for future research initiatives.

hertz
Télécharger la présentation

Advancements in Services Research: Enhancing Drug Abuse Treatment and Prevention Strategies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Services Research & the CTN:We keep getting better! Redonna K. Chandler, Ph.D. Chief, Services Research Branch Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse Department of Health and Human Services October 16, 2007 AHSR Conference

  2. Context: Services Research requires a different type of laboratory

  3. NIDA Blue Ribbon Task Force on Health Services Research Co-Chairs: Thomas McLellan, PhD, Constance Weisner, DrPH, MSW Andrea Barthwell, MD Caryn Blitz, PhD Rick Catalano, PhD Mady Chalk, PhD Linda Chinnia, MEd Lorraine Collins, PhD Wilson Compton, MD, MPE Michael Dennis, PhD Richard Frank, PhD Warren Hewitt, MS James Inciardi, PhD Marguerita Lightfoot, PhD Isaac Montoya, PhD Claire Sterk, PhD Janet Wood, MBA, MEd

  4. Previous Strategies • Encouraging applications: • Economics of Drug Abuse Treatment and Prevention Services (PA-05-111) • Services Research in the National Drug Abuse Clinical Trials Network (PA-03-011) • Economic Evaluation of Drug Abuse Treatment and Prevention Services for HIV/AIDS (PA-02-164)

  5. Why incorporate services measures in clinical trial? • Enhance results • Clue to mechanism of action? • Provide context • Prepare for dissemination • Cost and feasibility are key dimensions • Prepare for future research • Implementation science

  6. New Strategies: • Incorporate HS data points into protocol • Partner HS researchers with CTN researchers • Define HS question of interest • Determine time sensitive data • Determine data needed for larger R01

  7. Time Sensitive Data Key concept: Some data must be collected at baseline, others can be collected later.

  8. Economic data that can’t be collected later • Client treatment costs • Payment for services • In-kind payment (e.g. volunteer time) • Travel time and transportation costs to attend treatment • Dollar value of lost wages due to treatment attendance • Client DATCAP is typical instrument (www.datcap.com)

  9. Organizational Data that can’t be collected later • Readiness for change • Baseline • organizational climate & culture • job performance • org structure & business practices • staff efficiency • patient satisfaction • Staff intent to quit

  10. Summary • CTN provides rich lab for services research • NIDA is very interested in maximizing the use of this resource • We keep working collaborative to improve the process • We will continue moving forward

More Related